Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Refined grains, potatoes and sugary drinks can pack on extra pounds and cause blood sugar to spike, researchers noted. As a ...

His studies showed that a B vitamin deficiency could cause hardened arteries. It took the medical profession more than a ...

U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...

Climate change will affect human health as well as the environment. An Australian study shows millions will be at greater ...

Around one in five Brits are thought to be living with this potentially deadly disease, although many may not even realise ...

Discover the life-extending approaches to managing heart failure through medication adherence, lifestyle modifications, and ...

This disease is far more common among overweight or obese people and currently affects around one in five Brits ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor.

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

In Wisconsin, we experience higher rates of heart failure than any other state, but 80% of cardiac events are preventable, ...

Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's ...